Free Trial

Marsh & McLennan Companies, Inc. (NYSE:MMC) Shares Acquired by Union Bancaire Privee UBP SA

Marsh & McLennan Companies logo with Finance background

Union Bancaire Privee UBP SA increased its position in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 139.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,911 shares of the financial services provider's stock after acquiring an additional 69,314 shares during the period. Union Bancaire Privee UBP SA's holdings in Marsh & McLennan Companies were worth $28,487,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank bought a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $1,236,186,000. Stifel Financial Corp raised its stake in shares of Marsh & McLennan Companies by 551.0% in the fourth quarter. Stifel Financial Corp now owns 2,224,932 shares of the financial services provider's stock valued at $472,599,000 after acquiring an additional 1,883,146 shares during the last quarter. Amundi raised its stake in shares of Marsh & McLennan Companies by 81.1% in the fourth quarter. Amundi now owns 4,072,976 shares of the financial services provider's stock valued at $860,824,000 after acquiring an additional 1,823,807 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Marsh & McLennan Companies by 32,120.9% in the first quarter. GAMMA Investing LLC now owns 1,515,670 shares of the financial services provider's stock valued at $369,869,000 after purchasing an additional 1,510,966 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at approximately $207,278,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Price Performance

MMC traded down $2.21 during trading hours on Friday, hitting $217.19. The company's stock had a trading volume of 1,574,516 shares, compared to its average volume of 1,938,559. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.44. Marsh & McLennan Companies, Inc. has a 12 month low of $207.21 and a 12 month high of $248.00. The stock has a market cap of $107.02 billion, a price-to-earnings ratio of 26.52, a P/E/G ratio of 2.70 and a beta of 0.83. The business's 50-day moving average price is $226.42 and its 200-day moving average price is $225.29.

Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The financial services provider reported $3.06 earnings per share for the quarter, topping analysts' consensus estimates of $3.02 by $0.04. The company had revenue of $6.70 billion during the quarter, compared to analyst estimates of $7.08 billion. Marsh & McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%. During the same period in the prior year, the firm earned $2.89 earnings per share. Sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Keefe, Bruyette & Woods cut their price target on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating on the stock in a research report on Monday, April 21st. Barclays increased their price target on Marsh & McLennan Companies from $246.00 to $249.00 and gave the company an "equal weight" rating in a research report on Friday, April 11th. Wells Fargo & Company raised their price objective on shares of Marsh & McLennan Companies from $223.00 to $232.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 10th. UBS Group raised their target price on shares of Marsh & McLennan Companies from $259.00 to $261.00 and gave the stock a "buy" rating in a report on Wednesday, April 9th. Finally, Redburn Atlantic assumed coverage on shares of Marsh & McLennan Companies in a research note on Tuesday, March 25th. They set a "buy" rating and a $281.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $241.93.

View Our Latest Analysis on Marsh & McLennan Companies

Insider Buying and Selling

In other Marsh & McLennan Companies news, CEO Dean Michael Klisura sold 9,569 shares of Marsh & McLennan Companies stock in a transaction on Monday, March 31st. The shares were sold at an average price of $245.00, for a total transaction of $2,344,405.00. Following the sale, the chief executive officer now owns 20,935 shares of the company's stock, valued at $5,129,075. The trade was a 31.37% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Paul Beswick sold 2,237 shares of Marsh & McLennan Companies stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $246.00, for a total value of $550,302.00. Following the transaction, the senior vice president now owns 13,522 shares in the company, valued at approximately $3,326,412. This represents a 14.20% decrease in their position. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

About Marsh & McLennan Companies

(Free Report)

Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.

Featured Articles

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MMC)

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines